Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating
Pfizer (PFE) Gets a Buy From Cantor Fitzgerald
Pfizer Analyst Ratings
Eli Lilly and Co Analyst Ratings
Johnson & Johnson Analyst Ratings
Piper Sandler Adjusts Price Target on Elanco Animal Health to $16 From $19, Maintains Neutral Rating
Piper Sandler Sticks to Their Hold Rating for Elanco Animal Health (ELAN)
Elanco Animal Health Analyst Ratings
Catalent Analyst Ratings
Barclays Adjusts Catalent Price Target to $63 From $47
Eli Lilly and Co Analyst Ratings
Pfizer Analyst Ratings
Johnson & Johnson Analyst Ratings
Truist Securities Reiterates Buy on Eli Lilly and Co, Raises Price Target to $1000
Eli Lilly and Co Analyst Ratings
Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994
Johnson & Johnson Analyst Ratings
Merck & Co Analyst Ratings
Pfizer Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target